BackNeuroSense Therapeutics Ltd - Warrants (09/11/2026) Overview

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Current Cash

Track NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s current cash ($170K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$166000.00
↓ 95.09% YoYΔ $-3.21M vs prior year quarter

Peer trimmed avg / median

Loading

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Current Cash History

Loading

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) vs. peers: Current Cash Comparison

Loading

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) FAQ

As of the most recent data (December 2025), NRSNW shows a current cash of $170K. That compares with $3.4M in the prior-year period — down 95.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSNW's current cash is now $170K (was $3.4M) — a 95.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is outperforming or lagging.

Tracking NRSNW's current cash over time shows whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $170K That compares with $3.4M in the prior-year period — down 95.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170K) with ownership activity and broader fundamentals.